The Impact of Flavonoids and Omega-3 in Mitigating Frailty Syndrome to Improve Treatment Outcomes in Peripheral Artery Disease (PAD) Patients.
Study Design
- Studientyp
- Review
- Population
- Review of flavonoids and omega-3 in PAD with frailty
- Intervention
- The Impact of Flavonoids and Omega-3 in Mitigating Frailty Syndrome to Improve Treatment Outcomes in Peripheral Artery Disease (PAD) Patients. None
- Vergleichsgruppe
- None
- Primärer Endpunkt
- None
- Wirkungsrichtung
- Mixed
- Verzerrungsrisiko
- Unclear
Abstract
Peripheral artery disease (PAD) is a common vascular disorder in the elderly, often accompanied by frailty syndrome, which is associated with increased inflammation, oxidative stress, and functional decline. Nutritional strategies, particularly those involving bioactive compounds like flavonoids and omega-3 fatty acids, have been suggested as potential approaches to modulate these pathological processes. This narrative review summarizes current evidence regarding the anti-inflammatory and antioxidant effects of flavonoids and omega-3 fatty acids, and their possible roles in mitigating frailty syndrome in patients with PAD. We examine mechanistic pathways including NF-κB, AMPK, PI3K/Akt/mTOR, and Nrf2, which are implicated in chronic inflammation, endothelial dysfunction, and muscle wasting. Although studies in general and aging populations suggest beneficial effects of these compounds on vascular and muscle health, specific evidence in PAD patients remains limited. Flavonoids may reduce pro-inflammatory cytokine production and enhance antioxidant responses, while omega-3 fatty acids have shown potential in modulating inflammatory signaling and supporting vascular repair. Current data provide a basis for further investigation into the dietary modulation of frailty syndrome in PAD. Understanding the impact of these nutrients may offer insights into adjunctive strategies for improving patient outcomes.
Zusammenfassung
Current data provide a basis for further investigation into the dietary modulation of frailty syndrome in PAD, and mechanistic pathways including NF-κB, AMPK, PI3K/Akt/mTOR, and Nrf2 are examined, which are implicated in chronic inflammation, endothelial dysfunction, and muscle wasting.
Full Text
Used In Evidence Reviews
Similar Papers
The American journal of clinical nutrition · 1991
Omega-3 fatty acids in health and disease and in growth and development.
Journal of the American College of Nutrition · 2002
Omega-3 fatty acids in inflammation and autoimmune diseases.
Current atherosclerosis reports · 2004
Omega-3 fatty acids and inflammation.
Allergology international : official journal of the Japanese Society of Allergology · 2015
Role of omega-3 fatty acids and their metabolites in asthma and allergic diseases.
Prostaglandins & other lipid mediators · 2015
Omega-3 fatty acids and adipose tissue function in obesity and metabolic syndrome.
Journal of immunology (Baltimore, Md. : 1950) · 1994